ConCallIQ
Go Pro
FLUOROCHEM Diversified 13 Aug 2024

Gujarat Fluorochemicals Limited — Q1 FY25

GFL reported Q1 FY25 consolidated revenue of INR 1,176 crore (up 4% QoQ) and EBITDA of INR 262 crore (up 10% QoQ), with EBITDA margin at 22%.

neutral medium
Compare with...
Revenue ₹1,176 Cr
EBITDA ₹262 Cr
PAT ₹108 Cr
EBITDA Margin 22%
Duration
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

GFL reported Q1 FY25 consolidated revenue of INR 1,176 crore (up 4% QoQ) and EBITDA of INR 262 crore (up 10% QoQ), with EBITDA margin at 22%. PAT stood at INR 108 crore (up 7% QoQ). The sequential improvement was driven by a pickup in refrigerant volumes and prices, and continued growth in fluoropolymers, partially offset by logistics disruptions from the Red Sea crisis (impacting ~INR 70-80 crore revenue). Management reiterated confidence in reaching FY23 EBITDA run-rate of INR 1,700-1,800 crore by Q4 FY25, driven by fluoropolymer capacity utilization and new EV battery material supplies (LiPF6, electrolyte, PVDF) expected from Q4 FY25. Key risks include slower-than-expected ramp-up in battery materials and persistent Chinese competition in base fluoropolymers.

Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace

Focused Modules

Promises 2 promises

Promise Tracker

0 delivered, 0 close, 2 missed.

View Promises →
!Risks 4 risks

Risk Intelligence

Slow ramp-up in battery materials

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Red Sea revenue impact INR 70-80 crore
N/A

Revenue not booked due to shipping delays from Red Sea crisis, as disclosed by CEO.

EV customer engagements 20+
N/A

Number of potential customers engaged across US, EU, Japan, Korea, and India for battery materials.

Samples shipped to customers 50+
N/A

Product samples shipped globally for validation in battery materials segment.

Energy cost savings target INR 100+ crore
N/A

Expected annual savings from renewable energy contracts starting next year, per CEO.

What Changed vs Last Quarter

Comparing Q1 FY25 vs Q4 FY24
3 new guidance3 dropped4 new risk4 risk resolved
NEW
EBITDA run-rate target of INR 1,700-1,800 crore

Management expects to reach the FY23 EBITDA run-rate by Q4 FY25, give or take a quarter.

NEW
LFP plant commissioning in Q3 FY25

The LFP plant is expected to be commissioned in the third quarter of this financial year.

NEW
New fluoropolymer capacity utilization by Q4 FY25

Management expects to substantially utilize new fluoropolymer capacities by Q4 FY25.

UPDATED
Commercial supplies of battery materials from Q4 FY25

LiPF6, electrolyte, and PVDF binder commercial supplies expected to commence from Q4 FY2025.

DROPPED
FY25 EBITDA to be similar to FY23 levels (~INR 1,800-1,900 crore)

Management expects EBITDA to recover to FY23 levels, driven by fluoropolymer volume growth and new capacity ramp-up.

DROPPED
CapEx of INR 800 crore for battery chemicals in FY25

Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.

DROPPED
Fluoropolymer segment to see continuous growth in FY25

Green shoots visible; destocking phasing out. New capacities in FKM, PFA, PVDF, and micropowders to drive volume and value growth.

NEW RISK
Slow ramp-up in battery materials

Validation and approval cycles for EV battery materials are long, leading to a lag in revenue generation despite high CapEx.

NEW RISK
Chinese competition in fluoropolymers

Analyst raised concern about Chinese capacity additions pressuring pricing; management downplayed impact by focusing on high-value segments.

NEW RISK
Red Sea logistics disruption

Shipping delays via Cape of Good Hope caused ~INR 70-80 crore revenue deferment in Q1; may persist.

NEW RISK
PFAS regulatory risk

Investor asked about PFAS phase-out concerns; management argued fluoropolymers are exempt but acknowledged potential indirect impact.

RISK GONE
Sustained dumping from China in low-end fluoropolymers

Imports of lower-end grades (e.g., granular PTFE) continue to pressure domestic pricing and margins.

RISK GONE
Delayed recovery in refrigerant pricing

U.S. duty cuts and R-22 quota phase-out keep refrigerant prices subdued; no improvement expected in FY25.

RISK GONE
Funding risk for battery chemicals CapEx

Analyst raised concern about high net debt-to-EBITDA (1.8x) and INR 800 crore CapEx; management confirmed external funding process but no guarantee.

RISK GONE
Elevated operating costs impacting margins

Q4 operating costs rose due to year-end provisions, CSR, Red Sea logistics, and new plant expenses; sustainability unclear.

🤫 Topics management stopped discussing

30% EBITDA margin target for FY25

Mentioned in Q1 FY24, Q2 FY24, Q3 FY24

Management revised FY25 EBITDA guidance from 'better than FY23' to 'at par with FY23', indicating slower recovery.

CapEx of INR 800 crore for battery chemicals in FY25

Mentioned in Q3 FY24, Q4 FY24

Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.

Delayed destocking recovery in fluoropolymers

Mentioned in Q1 FY24, Q3 FY24

Legacy player inventory may take longer to deplete than expected, delaying volume recovery.

FY25 EBITDA to be similar to FY23 levels (~INR 1,800-1,900 crore)

Mentioned in Q3 FY24, Q4 FY24

Management expects EBITDA to recover to FY23 levels, driven by fluoropolymer volume growth and new capacity ramp-up.

Sustained dumping from China in low-end fluoropolymers

Mentioned in Q2 FY24, Q4 FY24

Imports of lower-end grades (e.g., granular PTFE) continue to pressure domestic pricing and margins.

Fast read

Guidance and risk preview

Top guidance EBITDA run-rate target of INR 1,700-1,800 crore

Management expects to reach the FY23 EBITDA run-rate by Q4 FY25, give or take a quarter.

Top risk Slow ramp-up in battery materials

Validation and approval cycles for EV battery materials are long, leading to a lag in revenue generation despite high CapEx.

View Risks →